Unitary Patent and UPC – the story so far

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Unitary Patent and UPC – the story so far

In-house counsel say they want more information on the Unitary Patent and UPC. Here’s some of our recent coverage – and a glimpse at what we have planned

upc20blog20150.jpg

Last week, we launched a survey on attitudes towards and expectations of the Unitary Patent and Unified Patent Court (UPC). The survey, which is aimed at in-house patent counsel, will be live until next week (and you can be in with a chance to win an iPad mini 3 if you complete it) so we are not yet ready to reveal the results. But some trends are already emerging.

One of the clearest findings so far is that in-house counsel do not feel there is enough information available on the planned system, despite the many articles and events addressing it.

We’re well aware of that challenge, and are commissioning a year-long series of articles on different aspects of the Unitary Patent and UPC. In fact, given the delays in launch and the volume of issues to discuss, the series is likely to last rather longer than a year.

These are the articles published so far (you will need a subscription to access them – discounts of up to 30% are available this week):

What we want from the Unitary Patent and UPC – written by myself and my colleague Emma Barraclough

Creative filing strategies for the Unitary Patent – by Adrian Tombling of Withers & Rogers and Andrea Fleuchaus of Fleuchaus & Gallo

The future of forum shopping in Europe – by Mark Ridgway and Annsley Merelle Ward of Allen & Overy

The Unitary Patent for non-litigators – by Michael Carter, Nick Smee, Luke Kempton and Nick Cunningham of Wragge Lawrence Graham

Don’t be afraid of bifurcation – by Gottfried Schüll and Arwed Burrichter of Cohausz & Florack

Rules that reflect different traditions (a response to the article above) – by Adam Cooke of DLA Piper

UPC map

Other pieces we have commissioned for this series include articles on the impact for the life sciences industries, on specific issues for non-European companies and on the factors to consider when deciding whether to opt-out.

If there are more topics you would like to see covered, or you would like to contribute to this series, please email me with details.

Readers interested in the Unitary Patent and UPC might also be interested in the following links: Unitary Patent and UPC resources – a guide and Where will the UPC be based? – an updated map.

You can see all our extensive coverage, including news, analysis and interviews, at managingip.com/UPC

For this week only, readers can get a discount of up to 30% on Managing IP subscriptions: register your interest here.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Plasseraud IP says it is eyeing AI and quantum computing expertise with new hire from Cabinet Netter
In the fifth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss the ‘Careers in Ideas’ network and how to open access to the profession
McGuireWoods’ focussed experimentation and disciplined execution of AI tools is sharpening its IP practice
As Marshall Gerstein celebrates its 70-year anniversary, Jeffrey Sharp, managing partner, reflects on lessons that shaped both his career and the firm’s success
News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points
Howard Hogan, IP partner at Gibson Dunn, says AI deepfakes are driving lawyers to rethink how IP protects creativity and innovation
Gift this article